Published February 28,2023
Subscribe
Two extra individuals in Equatorial Guinea have died of Marburg haemorrhagic fever, a cousin of the Ebola virus, bringing the toll of fatalities to 11, the authorities say.
“Two days ago, the monitoring system recorded eight notifications, including the deaths of two people with symptoms of the disease,” Health Minister Mitoha Ondo’o Ayekaba mentioned in a press release issued late Tuesday.
Work is underway “to strengthen assessment of the spread of the epidemic,” mentioned the assertion, learn on nationwide tv.
“Forty-eight contact cases have been documented, four of whom have developed symptoms, and three who have been quarantined in hospital,” it added.
The Marburg virus is a uncommon however extremely harmful pathogen that causes extreme fever, usually accompanied by bleeding and organ failure.
It is a part of the so-called filovirus household that additionally contains the Ebola virus, which has wreaked havoc in a number of earlier outbreaks in Africa.
The central African state introduced on February 13 that 9 individuals had died from Marburg between January 7 and February 7.
The UN’s World Health Organization (WHO) held an emergency session the next day.
The nationwide authorities have declared a well being alert within the distant northeastern province of Kie-Ntem province and within the neighbouring district of Mongomo, that are positioned on the border with Cameroon and Gabon.
Measures embody a lockdown plan applied in collaboration with the WHO.
In their assertion of February 13, the authorities had reported solely three circumstances of an infection along with the fatalities — people who had been being remoted with “mild symptoms” in hospital.
The pure host of the Marburg virus is the African fruit bat, which carries the virus however doesn’t fall sick from it.
But the animals can move the virus to primates in shut proximity, together with people, and human-to-human transmission then happens by means of contact with blood or different bodily fluids.
Fatality charges in confirmed circumstances have ranged from 24 % to 88 % in earlier outbreaks, relying on the virus pressure and case administration, based on the WHO.
There are at the moment no permitted vaccines or antiviral therapies.
Potential therapies, together with blood merchandise, immune therapies and drug therapies, in addition to early candidate vaccines are being evaluated, the WHO says.
Source: www.anews.com.tr
